Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols

Biochemical and Biophysical Research Communications

Volumn 307, Issue 4, 2003, Pages 1059-1065

  Dairou, Julien ^a,b   Atmane, Noureddine ^a   Dupret, Jean Marie ^a,b   Rodrigues Lima, Fernando ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Arylamine N acetyltransferase; Cysteine residue; Mixed disulfide; Reactive nitrogen species; Regulation

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ASCORBIC ACID; CYSTEINE; DISULFIDE; DITHIOTHREITOL; GLUTATHIONE; N ACETYL S NITROSOPENICILLAMINE; REACTIVE NITROGEN SPECIES;

ARTICLE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REGULATION; PRIORITY JOURNAL;

EID: 0038782331     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01311-1     Document Type: Article

References (40)

1. Pompeo F., Brooke E., Akane K., Mushtaq A., Sim E. The pharmacogenetics of NAT: structural aspects. Pharmacogenomics. 3:2002;19-30.
2. Hein D.W. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol. Lett. 112-113:2000;349-356.
3. Hein D. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 65:2002;506-507.
4. Matas N., Thygesen P., Stacey M., Risch A., Sim E. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet. Cell Genet. 77:1997;290-295.
5. Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39:1991;184-191.
6. Butcher N., Boukouvala S., Sim E., Minchin R.F. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J. 2:2002;30-42.
7. Meisel P. Arylamine N-acetyltransferases and drug response. Pharmacogenomics. 3:2002;349-366.
8. Blum M., Grant D.M., McBride W., Heim M., Meyer U.A. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 9:1990;193-203.
9. Sinclair J.C., Sandy J., Delgoda R., Sim E., Noble M.E. Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7:2000;560-564.
10. Rodrigues-Lima F., Deloménie C., Goodfellow G.H., Grant D.M., Dupret J.M. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem. J. 356:2001;327-334.
11. Rodrigues-Lima F., Dupret J.M. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active site loop. Biochem. Biophys. Res. Commun. 291:2002;116-123.
12. Sandy J., Mushtaq A., Kawamura A., Sinclair J., Noble M., Sim E. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis - an enzyme which inactivates the anti-tubercular drug, isoniazid. J. Mol. Biol. 318:2002;1071-1083.
13. Ignarro L.J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci. Rep. 19:1999;51-71.
14. Liu L., Stamler J.S. NO: an inhibitor of cell death. Cell Death Differ. 6:1999;937-942.
15. Moncada S. Nitric oxide and cell respiration: physiology and pathology. Verh. K. Acad. Geneeskd. Belg. 62:2000;171-179.
16. Stamler J.S., Lamas S., Fang F.C. Nitrosylation, the prototypic redox-based signaling mechanism. Cell. 106:2001;675-683.
17. Gaston B. Nitric oxide and thiol groups. Biochim. Biophys. Acta. 1411:1999;323-333.
18. Caselli A., Camici G., Manao G., Moneti G., Pazzagli L., Cappugi G., Ramponi G. Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J. Biol. Chem. 269:1994;24878-24882.
19. Rossig L., Fichtlscherer B., Breitschopf K., Haendeler J., Zeiher A.M., Mulsch A., Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J. Biol. Chem. 274:1999;6823-6826.
20. Persichini T., Colasanti M., Fraziano M., Colizzi V., Medana C., Polticelli F., Venturini G., Ascenzi P. Nitric oxide inhibits the HIV-1 reverse transcriptase activity. Biochem. Biophys. Res. Commun. 258:1999;624-627.
21. Venturini G., Salvati L., Muolo M., Colasanti M., Gradoni L., Ascenzi P. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 270:2000;437-441.
22. Salvati L., Mattu M., Colasanti M., Scalone A., Venturini G., Gradoni L., Ascenzi P. NO donors inhibit Leishmania infantum cysteine proteinase activity. Biochim. Biophys. Acta. 1545:2001;357-366.
23. Percival M., Ouellet M., Campagnolo C., Claveau D., Li C. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry. 38:1999;13574-13583.
24. Xian M., Chen X., Liu Z., Wang K., Wang P. Inhibition of papain by S-nitrosothiols. J. Biol. Chem. 275:2000;20467-20473.
25. Al-Sa'Doni H., Ferro A. S-nitrosothiols: a class of nitric oxide-donor drugs. Clin. Sci. 98:2000;507-520.
26. Mohr S., Hallak H., De Boitte A., Lapetina E., Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274:1999;9427-9430.
27. Wang K., Wen Z., Zhang W., Xian M., Cheng J., Wang P. Equilibrium and kinetics studies of transnitrosation between S-nitrosothiols and thiols. Biorg. Med. Chem. Lett. 11:2001;433-436.
28. Catani M., Bernassola F., Rossi A., Melino G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem. Biophys. Res. Commun. 249:1998;275-278.
29. Andres H.H., Klem A.J., Schopfer L.M., Harrison J.K., Weber W.W. On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits. J. Biol. Chem. 263:1988;7521-7527.
30. Dupret J.M., Grant D.M. Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2. J. Biol. Chem. 267:1992;7381-7385.
31. Delgoda R., Lian L., Sandy J., Sim E. NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium. Biochim. Biophys. Acta. 1620:2003;8-14.
32. Mohr S., Zech B., Lapetina E.G., Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun. 238:1997;387-391.
33. Persichini T., Colasanti M., Lauro G.M., Ascenzi P. Cysteine nitrosylation inactivates the HIV-1 protease. Biochem. Biophys. Res. Commun. 250:1998;575-576.
34. Bernassola F., Rossi A., Melino G. Regulation of transglutaminase by nitric oxide. Ann. NY Acad. Sci. 887:1999;83-91.
35. Butcher N.J., Ilett K.F., Minchin R.F. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid. Biochem. Pharmacol. 60:2000;1829-1836.
36. Srivastava S., Dixit B., Ramana K., Chandra A., Chandra D., Zacarias A., Petrash J., Bhatnagar A., Srivastava S. Structural and kinetic modification of aldose reductase by S-nitrosothiols. Biochem. J. 358:2001;111-118.
37. Mushtaq A., Payton M., Sim E. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity. J. Biol. Chem. 277:2002;12175-12181.
38. Xian M., Wang K., Chen X., Hou Y., McGill A., Chen X., Zhou B., Zhang Z., Chen J., Wang P. Inhibition of protein tyrosine phosphatases by low-molecular-weight S-nitrosothiols and S-nitrosylated human serum albumin. Biochem. Biophys. Res. Commun. 268:2000;310-314.
39. Venturini G., Colasanti M., Salvati L., Gradoni L., Ascenzi P. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease. Biochem. Biophys. Res. Commun. 267:2000;190-193.
40. Giles N., Giles G., Jacob C. Multiple roles of cysteine in biocatalysis. Biochem. Biophys. Res. Commun. 300:2003;1-4.